ArticleJournal of managed care & specialty pharmacy2020

Process and Clinical Outcomes of a Biosimilar Adoption Program with Infliximab-Dyyb.

Shubha Bhat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.